...Welcome, everybody. My name is Matt Sykes, Senior Life Sciences Tools and Diagnostics Analyst at Goldman Sachs. And I have the pleasure of having the NeoGenomics' management team to present to us today. I just wanted to introduce them real quickly. Doug VanOort, the Executive Chairman; Katheryn McKenzie, the CFO; Doug Brown is the Chief Strategy and Corporate Development Officer; Clive Morris, the CEO of Inivata; and Charlie Eidson, Manager of IR, Strategy and Corporate Development. Everybody, thank you very much for joining. We're really happy to have you here. And maybe I'll start out and turn it over to you, Doug VanOort, maybe just kind of give us sort of a background on NeoGenomics and maybe some of the recent trends you're seeing and just a bit of -- to kind of set the stage for us a little bit. Douglas M. VanOort ...